PD-L1 protein expression levels on both immune and tumor cells measured by IHC staining were decreased in the lo_lo group, especially in tumors with low (Q1) CDKN2A expression (Fig. 5a, left). The gene discussed is CDKN2A; the disease is neoplasm.